Publication | Closed Access

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

Clinical ImmunologyClinical ResponseAutoimmune DiseaseMedicineImmunologyInterferon-beta TherapyImmunologic MechanismAutoimmunityBrain-immune InteractionMultiple SclerosisImmunotherapyNeuroimmunologyCell BiologyNatural Killer Cells